What did @drmichaelsays actually say?
The creator ran through six peptide categories in a single TikTok: insulin mimetics (GLP-1s, GIP, glucagon), copper peptides like GHK-Cu, growth hormone secretagogues (including CJC-1295 and what they called "sirmaryllin" and "pamaryllin"), cytoprotective peptides like BPC-157, melanocortin agonists like melanotan II, and mitochondrial-derived peptides working through the AMPK pathway. They closed with a blunt disclaimer: peptides outside the weight-loss and diabetes category are "unregulated" and "untested," and influencers selling them "are gonna tell you a lot of shit."
The video is genuinely more honest than most peptide content on TikTok. That said, several classification choices and mechanism descriptions are imprecise enough to matter, and at least one category gets mislabeled in a way that could mislead someone trying to do actual research.
Does the science back this up?
Mostly, but with real gaps. The GLP-1 receptor agonist classification is solid, the GHK-Cu collagen claim is supported by human cell and animal data, and the growth hormone secretagogue category is real and well-characterized. The AMPK-mitochondria framing for mitochondrial-derived peptides is directionally correct.
Where it gets shakier is BPC-157. Calling it a "cytoprotective peptide" that works through nitric oxide pathways is a partial picture at best. BPC-157's proposed mechanisms include modulation of the NO system, but also involve the VEGF pathway, FAK-paxillin signaling, and interaction with growth hormone receptors, according to Sikiric et al. (2018, Current Pharmaceutical Design). Framing it narrowly as a nitric oxide peptide understates how poorly understood its full mechanism actually is in humans, since the bulk of mechanistic data comes from rodent models. A viewer could walk away thinking BPC-157's mechanism is settled science. It is not.
What did they get wrong (or right)?
Credit where it is due: the warning about melanotan II is correct and overdue. The creator says they "wouldn't recommend" it, which is the right call. Melanotan II is a non-selective melanocortin receptor agonist with documented risks including nausea, spontaneous erections, and reported associations with melanoma progression in case studies (Cosgarea et al., 2020, JAMA Dermatology). The creator should have been more forceful here, but at least they flagged it.
The category name "cytoprotective" for BPC-157 is also a reasonable clinical shorthand used in some of the original Croatian research. That is fair.
What they got wrong: CJC-1295 is a GHRH analogue, not a ghrelin mimetic. Grouping it in the same breath as ipamorelin (a ghrelin receptor agonist) without distinguishing the two mechanisms is a meaningful error for anyone trying to understand how these compounds differ pharmacologically. They also listed "MK-677" under the mitochondrial-derived peptide category, calling it the most common peptide in that group. MK-677 (ibutamoren) is actually a growth hormone secretagogue and belongs in the prior category, not with mitochondrial peptides like humanin or MOTS-c. That is a factual misclassification.
What should you actually know?
The creator's closing statement is the most accurate thing in the video: outside of approved GLP-1 drugs like semaglutide, these peptides are largely untested in controlled human trials. That is not a minor caveat. It means efficacy claims, dosing assumptions, and safety profiles for most of what gets sold online are built almost entirely on animal studies and anecdote.
The regulatory picture is also more specific than "unregulated" suggests. In the US, many research peptides are sold legally as "not for human use" lab reagents. Some, like BPC-157 and CJC-1295, have been on FDA compounding restriction lists. The FDA placed BPC-157 on its list of bulk drug substances that may not be compounded in 2023. That is a material fact the video omits entirely.
- If you are considering any of these compounds, the starting point is a licensed provider with actual lab access, not a TikTok comment section or a grey-market research chemical website.
- "Doing your research" on unregulated peptides means reading primary literature, not Reddit threads.
The bottom line
This video is better than average for TikTok peptide content. The creator does not hype miracle outcomes, they warn about melanotan II, and they tell viewers to verify sourcing. But the MK-677 misclassification is real, the BPC-157 mechanism is oversimplified, and the regulatory nuance around compounding is missing entirely. Treat this as a rough orientation to the space, not a clinical reference.